Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Vilaprisan in Women With Symptomatic Endometriosis
CTR20180528Phase 2Terminated
- Sponsor
- Bayer
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vilaprisan in endometriosis, sponsored by Bayer. Started Nov 2018; status: terminated.
02
Drugs
vilaprisan
03
Conditions
endometriosis
Beyond the preview
Go deeper on CTR20180528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180528.